Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy

J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e128-e129. doi: 10.1111/jdv.13403. Epub 2015 Oct 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adalimumab / therapeutic use*
  • Anti-Inflammatory Agents / therapeutic use*
  • Humans
  • Interleukin-17 / metabolism*
  • Psoriasis / drug therapy*
  • Psoriasis / metabolism
  • Severity of Illness Index
  • Tears / metabolism*

Substances

  • Anti-Inflammatory Agents
  • Interleukin-17
  • Adalimumab